Pluri Inc. (Pluristem Therapeutics Inc.) 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on February 11, 2009, by Pluristem Therapeutics Inc., a Nevada corporation. The report addresses a regulatory matter concerning the company's listing status on the Nasdaq Stock Market, with the earliest event reported occurring on February 5, 2009.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a compliance issue regarding shareholder approval rules and does not contain financial performance data.
Material Changes
The material change reported is the resolution of a Nasdaq listing deficiency. On February 5, 2009, the company received a notification that it violated Nasdaq Marketplace Rule 4350(i)(1)(D)(ii) regarding shareholder approval for the sale of units (common shares and warrants) in November and December 2008. The violation involved the issuance of 1,662,500 units and an option to purchase an additional 886,667 units.
Outlook, Risks, and Management Commentary
Management resolved the deficiency by securing an agreement from the investors involved. The investors agreed that no warrants or options to purchase additional units would be exercised until six months after the original agreement dates. Consequently, the Nasdaq Staff determined the company had regained compliance. The matter was officially closed following the issuance of a press release on February 11, 2009. No other risks, contingencies, or unusual items are detailed in this filing.
Key Facts for Investor Verification
- The company received a Nasdaq deficiency notice on February 5, 2009, for violating shareholder approval rules.
- The violation stemmed from the sale of approximately 2.55 million units (shares and warrants) in late 2008 without prior shareholder approval.
- Compliance was restored through an investor agreement to delay the exercise of warrants and options for six months.
- Nasdaq has confirmed the matter is closed as of the filing date.